Speaker Profile
Biography
P Hinestrosa is a scientist and builder working at the intersection of biology, data, and technology. His work focuses on extracting meaningful biological signals from complex systems, with an emphasis on biomarker discovery and multi-omic analytics that can move diagnostics earlier in disease progression. He brings a deep curiosity for how molecular information encodes health and disease, and how that information can be transformed into reliable, scalable tools used in the real world.JP has trained across engineering, national laboratory research, and international scientific environments, giving him a broad perspective on both fundamental science and translational impact. At Xzōm, he helps shape the scientific and analytical foundations of a platform designed to learn continuously from real-world data turning biological complexity into actionable insight that improves with use.
Talk
Early Enough: Exosomes Power Next-Generation Detection
Xzōm is building a first-in-class, exosome-based foundational technology platform that delivers actionable biomarker insights in under 30 minutes. By unifying exosome isolation, biomarker analysis, and AI that is point of care capable Xzōm enables early detection, smarter monitoring, and a continuously learning precision medicine platform across cancer, neurodegeneration, and other diseases.
Clinical & Research Tools Showcase:
Xzom, Inc.
Xzōm is a life sciences company developing a comprehensive, exosome-based biomarker platform that delivers rapid, actionable results. Our technology empowers partners to build and scale next-generation clinical applications while continuously learning from real-world use to enable earlier detection and better outcomes.
Session Abstract – PMWC 2026 Silicon Valley
The PMWC 2026 Clinical & Research Tools Showcase will provide a 15-30 minute time slot for selected companies in this space. The Clinical & Research Tools is a showcase for innovative technologies that are used for the analysis of genetic variation and function, helping to advance breakthroughs in genetic health, rare disease conditions on individuals of all ages, complex diseases and cancer care. Next-generation sequencing (NGS) and microarray technologies empower rapidly evolving genomic revolution.




